Overview, Prevention, and Treatment of Rabies
dc.contributor.author | Nigg, Andrea Julia | en_US |
dc.contributor.author | Walker, Pamela L. | en_US |
dc.date.accessioned | 2012-03-16T15:54:30Z | |
dc.date.available | 2012-03-16T15:54:30Z | |
dc.date.issued | 2009-10 | en_US |
dc.identifier.citation | Nigg, Andrea Julia; Walker, Pamela L. (2009). "Overview, Prevention, and Treatment of Rabies." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29(10). <http://hdl.handle.net/2027.42/90104> | en_US |
dc.identifier.issn | 0277-0008 | en_US |
dc.identifier.issn | 1875-9114 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/90104 | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Rabies Vaccine | en_US |
dc.subject.other | Human Rabies Immune Globulin | en_US |
dc.subject.other | HRIG | en_US |
dc.subject.other | Antivirals | en_US |
dc.subject.other | Immunizations | en_US |
dc.subject.other | Human Rabies. | en_US |
dc.subject.other | Milwaukee Protocol | en_US |
dc.subject.other | Rabies Virus | en_US |
dc.title | Overview, Prevention, and Treatment of Rabies | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | College of Pharmacy, University of Michigan, Ann Arbor, Michigan. | en_US |
dc.contributor.affiliationum | Department of Pharmacy Services, University of Michigan Hospital | en_US |
dc.identifier.pmid | 19792992 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/90104/1/phco.29.10.1182.pdf | |
dc.identifier.doi | 10.1592/phco.29.10.1182 | en_US |
dc.identifier.source | Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | en_US |
dc.identifier.citedreference | Howdieshell TR, Heffernan D, DiPiro JT. Surgical infection society guidelines for vaccination after traumatic injury. Surg Infect 2006; 7 ( 3 ): 275 – 303. | en_US |
dc.identifier.citedreference | Novartis. RabAvert (rabies vaccine) package insert. Marburg, Germany; 2004. | en_US |
dc.identifier.citedreference | Fishbein DB, Sawyer LA, Reid‐Sanden FL. Administration of human diploid‐cell rabies vaccine in the gluteal area [letter]. N Engl J Med 1988; 318 ( 2 ): 124. | en_US |
dc.identifier.citedreference | Anonymous. Red book, 2008 ed. Montvale, NJ: Thomson Healthcare, 2008. | en_US |
dc.identifier.citedreference | Eremeeva ME, Dasch GA. CDC travelers' health yellow book: rickettsial infections, 2008. Available from http:wwwn.cdc.govtravelyellowBookCh4‐Rickettsial.aspx. Accessed November 19, 2008. | en_US |
dc.identifier.citedreference | Talecris Biotherapeutics. HyperRAB S/D (human rabies immune globulin) package insert. Irmo, SC; 2008. | en_US |
dc.identifier.citedreference | Sanofi Pasteur. Imogam Rabies HT (human rabies immune globulin) package insert. Lyon, France; 1999. | en_US |
dc.identifier.citedreference | Centers for Disease Control and Prevention. Bats and rabies: a public health guide, 2008. Available from http:www.cdc.govrabiesbats.html. Accessed November 19, 2008. | en_US |
dc.identifier.citedreference | Centers for Disease Control and Prevention. Recommendation of the immunization practices advisory committee (ACIP) rabies prevention—United States, 1984. MMWR Morb Mortal Wkly Rep 1984; 33 ( 28 ): 393 – 408. | en_US |
dc.identifier.citedreference | World Health Organization. Technical report series. WHO expert consultation on rabies, 2005. Available from http:www.who.intrabies931enindex.html. Accessed November 19, 2008. | en_US |
dc.identifier.citedreference | McDermid RC, Saxinger L, Lee B. Human rabies encephalitis following bat exposure: failure of therapeutic coma. CMAJ 2008; 178 ( 5 ): 557 – 61. | en_US |
dc.identifier.citedreference | Centers for Disease Control and Prevention. ACIP provisional recommendations for the prevention of human rabies, July 10, 2009. Available from http:www.cdc.govvaccinesrecsprovisionaldownloadsrabies‐july2009‐508.pdf. Accessed July 15, 2009. | en_US |
dc.identifier.citedreference | Jackson AC, Warrell MJ, Rupprecht CE. Management of rabies in humans. Clin Infect Dis 2003; 36: 60 – 3. | en_US |
dc.identifier.citedreference | Willoughby RE, Tieves KS, Hoffman GM. Survival after treatment of rabies with induction of coma. N Engl J Med 2005; 352 ( 24 ): 2508 – 14. | en_US |
dc.identifier.citedreference | Hemachudha T, Sunsaneewitayakul B, Desudchit T. Failure of therapeutic coma and ketamine for therapy of human rabies. J Neurovirology 2006; 12 ( 5 ): 407 – 9. | en_US |
dc.identifier.citedreference | Medical College of Wisconsin. The Milwaukee protocol, 2007. Available from http:www.chw.orgdisplayPPFDocID33223router.asp. Accessed December 22, 2008. | en_US |
dc.identifier.citedreference | Centers for Disease Control and Prevention. Human rabies—Indiana and California, 2006. MMWR Morb Mortal Wkly Rep 2007; 56 ( 15 ): 361 – 5. | en_US |
dc.identifier.citedreference | Lockhart BP, Tordo N, Tsiang H. Inhibition of rabies virus transcription in rat cortical neurons with the dissociative anesthetic ketamine. Antimicrob Agents Chemother 1992; 36 ( 8 ): 1750 – 5. | en_US |
dc.identifier.citedreference | Trevor AJ, White PF. General anesthetics. In: Katzung BG, ed. Basic and clinical pharmacology, 10th ed. New York: McGraw‐Hill, 2007: 395 – 411. | en_US |
dc.identifier.citedreference | Humar M, Pischke SE, Loop T. Barbiturates directly inhibit the calmodulin/calcineurin complex: a novel mechanism of inhibition of nuclear factor of activated T cells. Mol Pharmacol 2004; 65 ( 2 ): 350 – 61. | en_US |
dc.identifier.citedreference | Trapani G, Altomare C, Liso G, Sanna E, Biggio G. Propofol in anesthesia. Mechanism of action, structure‐activity relationships, and drug delivery. Curr Med Chem 2000; 7 ( 2 ): 249 – 71. | en_US |
dc.identifier.citedreference | Evers AS, Crowder CM, Balser JR. General anesthetics. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman & Gilman's the pharmacological basis of therapeutics, 11th ed. New York: McGraw‐Hill, 2006: 341 – 68. | en_US |
dc.identifier.citedreference | Noah DL, Drenzek CL, Smith JS. Epidemiology of human rabies in the United States, 1980 to 1996. Ann Intern Med 1998; 128 ( 11 ): 922 – 30. | en_US |
dc.identifier.citedreference | Bussereau F, Picard M, Blancou J, Sureau P. Treatment of rabies in mice and foxes with antiviral compounds. Acta Virol 1988; 32 ( 1 ): 33 – 49. | en_US |
dc.identifier.citedreference | Warrell MJ, White NJ, Looareesuwan S. Failure of interferon alfa and tribavirin in rabies encephalitis. BMJ 1989; 299 ( 6703 ): 830 – 3. | en_US |
dc.identifier.citedreference | Superti F, Seganti L, Pana A, Orsi N. Effect of amantadine on rhabdovirus infection. Drugs Exp Clin Res 1985; 11 ( 1 ): 69 – 74. | en_US |
dc.identifier.citedreference | Jackson AC. Recovery from rabies. N Engl J Med 2005; 352 ( 24 ): 2549 – 50. | en_US |
dc.identifier.citedreference | Centers for Disease Control and Prevention. Rabies—2008. Available from http:www.cdc.govrabies. Accessed December 16, 2008. | en_US |
dc.identifier.citedreference | Amsden JR, Warmack TS, Gubbins PO. Zoonoses. In: Schumock GT, Dunsworth TS, Brundage DM, eds. Pharmacotherapy self‐assessment program. Kansas City, MO: American College of Clinical Pharmacy, 2004: 1 – 42. | en_US |
dc.identifier.citedreference | Centers for Disease Control and Prevention. Recovery of a patient from clinical rabies—Wisconsin, 2004. MMWR Morb Mortal Wkly Rep 2004; 53 ( 50 ): 1171 – 3. | en_US |
dc.identifier.citedreference | Bergquist L. Milwaukee journal sentinal. Brazilian boy with rabies in recovery. November 16, 2008. Available from http:www.jsonline.comfeatureshealth34532044.html. Accessed December 22, 2008. | en_US |
dc.identifier.citedreference | Rupprecht CE, Gibbons RV. Prophylaxis against rabies. N Engl J Med 2004; 351 ( 25 ): 2626 – 35. | en_US |
dc.identifier.citedreference | Hemachudha T, Laothamatas J, Rupprecht CE. Human rabies: a disease of complex neuropathogenetic mechansims and diagnostic challenges. Lancet Neurol 2002; 1: 101 – 9. | en_US |
dc.identifier.citedreference | Leung AK, Davies HD, Hon KL. Rabies: epidemiology, pathogenesis, and prophylaxis. Adv Ther 2007; 24 ( 6 ): 1340 – 6. | en_US |
dc.identifier.citedreference | Messenger SL, Smith JS, Rupprecht CE. Emerging epidemiology of bat‐associated cryptic cases of rabies in humans in the United States. Clin Infect Dis 2002; 35 ( 6 ): 738 – 47. | en_US |
dc.identifier.citedreference | Srinivasan A, Burton EC, Kuehnert MJ. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005; 352 ( 11 ): 1103 – 11. | en_US |
dc.identifier.citedreference | Jackson AC. Rabies. Neurol Clin 2008; 26: 717 – 26. | en_US |
dc.identifier.citedreference | Meslin FX. Rabies as a traveler's risk, especially in high‐endemicity areas. J Travel Med 2005; 12 ( suppl 1 ): S30 – 40. | en_US |
dc.identifier.citedreference | Manning SE, Rupprecht CE, Fishbein, D,. Human rabies prevention—United States, 2008: recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2008; 57 ( RR‐3 ): 1 – 28. | en_US |
dc.identifier.citedreference | Sanofi Pasteur. Imovax rabies (rabies vaccine) package insert. Swiftwater, PA; 2005. | en_US |
dc.identifier.citedreference | Centers for Disease Control and Prevention. Rabies vaccine supply situation, 2009. Available from http:www.cdc.govrabiesnewsRabVaxupdate.html. Accessed April 13, 2009. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.